Ovid Therapeutics OVID
NASDAQ OVID
$2.47 +0.11 (+4.66%)
At close: Oct 21, 2026 · 4:00 PM EDT

Ovid Therapeutics (OVID) Current Deferred Revenue (2020)

Updated

Ovid Therapeutics' Current Deferred Revenue came in at $2.21 million for Q4 2020, down 29.8% from the prior quarter.

Analysis

Ovid Therapeutics (OVID) Current Deferred Revenue (2020) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Ovid Therapeutics 485.74 Mn 117.76 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 2.21 Mn
Sep 30, 2020 3.15 Mn
API Access

Ovid Therapeutics Current Deferred Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=OVID&period=max&api_key=YOUR_API_KEY